2010
DOI: 10.3410/m2-10
|View full text |Cite
|
Sign up to set email alerts
|

Pulmonary hypertension in hemolytic anemias

Abstract: Pulmonary hypertension (PH) has been reported with nearly all forms of the inherited as well as the acquired hemolytic anemias. Recent research investigating the pathophysiology of PH in sickle cell disease and thalassemia has helped elucidate the central role of hemolysis-mediated endothelial dysfunction in the development of PH in these populations. Although the most appropriate treatment of PH in patients with hemolytic anemia is not clearly defined, the associated significant increased risk of death unders… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
16
0

Year Published

2012
2012
2021
2021

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 18 publications
(16 citation statements)
references
References 47 publications
0
16
0
Order By: Relevance
“…But, whether hemolysis is a cause or effect of hypertension remains unclear. Most studies suggest that hypertension is a complication of hemolysis and associated with hemolytic anemia [ 35 ]. In addition to this, blood disorders such as polycythemia vera and essential thrombocythemia, causes hypertension [ 20 ].…”
Section: Discussionmentioning
confidence: 99%
“…But, whether hemolysis is a cause or effect of hypertension remains unclear. Most studies suggest that hypertension is a complication of hemolysis and associated with hemolytic anemia [ 35 ]. In addition to this, blood disorders such as polycythemia vera and essential thrombocythemia, causes hypertension [ 20 ].…”
Section: Discussionmentioning
confidence: 99%
“…Anaemia is associated with higher cardiovascular risk, higher blood pressure values, and lower dipping status in hypertensive patients, and haemoglobin should be monitored in hypertensive patients [33]. During HTN, there is a possibility of haemolysis [34] [35] [36] [37]. Previous studies suggest that hypertension is a complication of hemolysis and associated with haemolytic anaemia [38].…”
Section: Discussionmentioning
confidence: 99%
“…Given that pulmonary hypertension is a major complication in many haemolytic conditions, administration of inhaled NO in acute haemolytic conditions may be beneficial. However, NO-based therapies may be limited in their efficacy, as exemplified by recent early termination of a large multicentre trial where sickle cell patients with pulmonary hypertension receiving PDE5 inhibitor had more severe pain crises leading to an increase in hospitalisations 8 9. It has not been demonstrated whether there is benefit to the use of inhaled NO for patients with pulmonary artery hypertension in the setting of AIHA.…”
Section: Discussionmentioning
confidence: 99%